Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications

<p dir="ltr">The global burden of breast cancer (BC) is increasing significantly. This trend is caused by several factors such as late diagnosis, limited treatment options for certain BC subtypes, drug resistance which all lead to poor clinical outcomes. Recent research has reported...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Gulab Sher (12984698) (author)
مؤلفون آخرون: Nadia Aziz Salman (17058033) (author), Abdul Q. Khan (14153247) (author), Kirti S. Prabhu (4246144) (author), Afsheen Raza (492657) (author), Michal Kulinski (3520070) (author), Said Dermime (79420) (author), Mohammad Haris (564809) (author), Kulsoom Junejo (9327448) (author), Shahab Uddin (154400) (author)
منشور في: 2022
الموضوعات:
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513559437770752
author Gulab Sher (12984698)
author2 Nadia Aziz Salman (17058033)
Abdul Q. Khan (14153247)
Kirti S. Prabhu (4246144)
Afsheen Raza (492657)
Michal Kulinski (3520070)
Said Dermime (79420)
Mohammad Haris (564809)
Kulsoom Junejo (9327448)
Shahab Uddin (154400)
author2_role author
author
author
author
author
author
author
author
author
author_facet Gulab Sher (12984698)
Nadia Aziz Salman (17058033)
Abdul Q. Khan (14153247)
Kirti S. Prabhu (4246144)
Afsheen Raza (492657)
Michal Kulinski (3520070)
Said Dermime (79420)
Mohammad Haris (564809)
Kulsoom Junejo (9327448)
Shahab Uddin (154400)
author_role author
dc.creator.none.fl_str_mv Gulab Sher (12984698)
Nadia Aziz Salman (17058033)
Abdul Q. Khan (14153247)
Kirti S. Prabhu (4246144)
Afsheen Raza (492657)
Michal Kulinski (3520070)
Said Dermime (79420)
Mohammad Haris (564809)
Kulsoom Junejo (9327448)
Shahab Uddin (154400)
dc.date.none.fl_str_mv 2022-08-25T00:00:00Z
dc.identifier.none.fl_str_mv 10.1016/j.semcancer.2020.08.009
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/Epigenetic_and_breast_cancer_therapy_Promising_diagnostic_and_therapeutic_applications/24210645
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Oncology and carcinogenesis
Epigenetics
Breast cancer
DNA methylation
Epigenetic drugs
Biomarkers
dc.title.none.fl_str_mv Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <p dir="ltr">The global burden of breast cancer (BC) is increasing significantly. This trend is caused by several factors such as late diagnosis, limited treatment options for certain BC subtypes, drug resistance which all lead to poor clinical outcomes. Recent research has reported the role of epigenetic alterations in the mechanism of BC pathogenesis and its hallmarks include drug resistance and stemness features. The understanding of these modifications and their significance in the management of BC carcinogenesis is challenging and requires further attention. Nevertheless, it promises to provide novel insight needed for utilizing these alterations as potential diagnostic, prognostic markers, predict treatment efficacy, as well as therapeutic agents. This highlights the importance of continuing research development to further advance the existing knowledge on epigenetics and BC carcinogenesis to overcome the current challenges. Hence, this review aims to shed light and discuss the current state of epigenetics research in the diagnosis and management of BC.</p><h2>Other Information</h2><p dir="ltr">Published in: Seminars in Cancer Biology<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.semcancer.2020.08.009" target="_blank">https://dx.doi.org/10.1016/j.semcancer.2020.08.009</a></p>
eu_rights_str_mv openAccess
id Manara2_507ffbf782294568d0c23de4064eb8e8
identifier_str_mv 10.1016/j.semcancer.2020.08.009
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/24210645
publishDate 2022
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applicationsGulab Sher (12984698)Nadia Aziz Salman (17058033)Abdul Q. Khan (14153247)Kirti S. Prabhu (4246144)Afsheen Raza (492657)Michal Kulinski (3520070)Said Dermime (79420)Mohammad Haris (564809)Kulsoom Junejo (9327448)Shahab Uddin (154400)Biomedical and clinical sciencesOncology and carcinogenesisEpigeneticsBreast cancerDNA methylationEpigenetic drugsBiomarkers<p dir="ltr">The global burden of breast cancer (BC) is increasing significantly. This trend is caused by several factors such as late diagnosis, limited treatment options for certain BC subtypes, drug resistance which all lead to poor clinical outcomes. Recent research has reported the role of epigenetic alterations in the mechanism of BC pathogenesis and its hallmarks include drug resistance and stemness features. The understanding of these modifications and their significance in the management of BC carcinogenesis is challenging and requires further attention. Nevertheless, it promises to provide novel insight needed for utilizing these alterations as potential diagnostic, prognostic markers, predict treatment efficacy, as well as therapeutic agents. This highlights the importance of continuing research development to further advance the existing knowledge on epigenetics and BC carcinogenesis to overcome the current challenges. Hence, this review aims to shed light and discuss the current state of epigenetics research in the diagnosis and management of BC.</p><h2>Other Information</h2><p dir="ltr">Published in: Seminars in Cancer Biology<br>License: <a href="http://creativecommons.org/licenses/by/4.0/" target="_blank">http://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.1016/j.semcancer.2020.08.009" target="_blank">https://dx.doi.org/10.1016/j.semcancer.2020.08.009</a></p>2022-08-25T00:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.1016/j.semcancer.2020.08.009https://figshare.com/articles/journal_contribution/Epigenetic_and_breast_cancer_therapy_Promising_diagnostic_and_therapeutic_applications/24210645CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/242106452022-08-25T00:00:00Z
spellingShingle Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
Gulab Sher (12984698)
Biomedical and clinical sciences
Oncology and carcinogenesis
Epigenetics
Breast cancer
DNA methylation
Epigenetic drugs
Biomarkers
status_str publishedVersion
title Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
title_full Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
title_fullStr Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
title_full_unstemmed Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
title_short Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
title_sort Epigenetic and breast cancer therapy: Promising diagnostic and therapeutic applications
topic Biomedical and clinical sciences
Oncology and carcinogenesis
Epigenetics
Breast cancer
DNA methylation
Epigenetic drugs
Biomarkers